🇺🇸 FDA
Patent

US 12156862

Medicaments for the treatment of vasoconstriction related diseases or disorders

granted A61KA61K31/353A61K31/4025

Quick answer

US patent 12156862 (Medicaments for the treatment of vasoconstriction related diseases or disorders) held by Sulfateq B.V. expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sulfateq B.V.
Grant date
Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/353, A61K31/4025, A61K31/496, A61K31/5377